Bird Flu

Ministry of Health

• Avian influenza 
• Highly pathogenic avian influenza: Recommendations for personal protective equipment for workers and employers

Public Health Agency of Canada

• Avian Influenza A (H5N1): Symptoms and treatment 
• Cleaning and disinfection: avian influenza  
• Prevent the spread of avian influenza in wild birds: poster 

Wild bird surveillance is conducted through a collaboration between:

• CFIA (HPAI in wildlife dashboard)
• Environment and Climate Change Canada
• Public Health Agency of Canada
• Canadian Wildlife Health Cooperative (CWHC)

Report to the Health Unit immediately by fax (705-482-0670) and phone at 705-474-1400 or toll free at 1-800-563-2808, ext. 5229 if avian influenza is suspected or confirmed as per Ontario Regulation 135/18 and amendments under the Health Protection Promotion Act, R.S.O., c.H.7.

After hours, weekends, and holidays, call 705-474-1400 then press 0 to speak with the Answering Service. The on-call CDC Public Health Nurse will get back to you as soon as possible.

Report sick or dead wild birds that are on municipal property to your local municipality and on the Canadian Wildlife Health Cooperative online reporting tool. Check with your local municipality for approved methods of disposing of dead birds. Large numbers of dead wild birds should be managed as instructed by the Canadian Wildlife Health Cooperative.

Contact the Health Unit. All ill individuals should self-isolate and follow measures to help reduce the spread of influenza and other respiratory viruses, including covering your mouth and nose when coughing or sneezing, physical distancing, wearing a mask if able when physical distancing is not possible, regular hand hygiene, improving indoor ventilation (e.g., opening windows), and regularly cleaning and disinfecting commonly touched surfaces and objects. The length of exclusion will depend on the strain of influenza identified.

Follow the direction of your healthcare provider, public health case manager, or occupational health at your workplace.

Health Canada has authorized and purchases a human vaccine against avian influenza (HVAI), Arepanrix H5N1. The National Advisory Committee on Immunization (NACI) has outlined factors for provinces and territories to consider when deciding whether and when to start offering HVAI to key populations based on their known or potential risk of exposure to sources of avian influenza A(H5N1). See Rapid response: Preliminary guidance on human vaccination against avian influenza in a non-pandemic context as of December 2024.

All individuals 6 months of age and older are recommended to receive an authorized, age-appropriate seasonal influenza vaccine each year. 

In addition to routine practices, individuals under investigation and individuals with probable or confirmed avian influenza should be placed on airborne, droplet, and contact precautions, which includes placing the individual in an airborne infection isolation room (AIIR), where possible. See Public Health Ontario: Prevention and Management of Avian Influenza in Health Care Settings Fact Sheet and Public Health Agency of Canada: Interim recommendations for infection prevention and control of avian influenza in healthcare settings.

Consider and test for avian influenza (in addition to other causes of acute respiratory illness) if the individual has compatible symptoms and reports exposure to potentially infected birds, wildlife, livestock or other animals. Obtain both a nasopharyngeal swab and a throat swab. The selection of a positive influenza specimen for submission for influenza A subtyping or whole genome sequencing is guided by criteria determined by the Public Health Ontario Laboratory. See Public Health Ontario: Avian Influenza – Real-time PCR for additional information.

Antiviral agents can be used to treat suspected, probable, or confirmed avian influenza A(H5N1) cases. The ideal time to begin antiviral treatment is within the first 48 hours of symptom onset. Treatment can be initiated while awaiting confirmatory test results and should not be delayed.  See Public Health Agency of Canada: Guidance on human health issues related to avian influenza in Canada (HHAI) for additional information on antiviral recommendations including treatment dosage guidelines.

Individuals who have had exposure to avian influenza A(H5N1) and who do not have any signs and symptoms should have a clinical assessment to determine if post-exposure prophylaxis are appropriate based on exposure risk. See Public Health Agency of Canada: Guidance on human health issues related to avian influenza in Canada (HHAI) – 11.2.2 Antiviral Prophylaxis for additional information on antiviral recommendations, including dosage guidelines.

Public Health Ontario

• Highly Pathogenic Avian Influenza: Infection Prevention and Control Guidance for Veterinary Clinics

Ministry of Health

• Avian influenza in poultry
• Animal health updates and veterinary advisories